Leading the Charge

We’ve built a company poised to produce transformative pharmaceutical solutions by bringing together leaders steeped in all the functions needed to bring new drugs to life. With a deeply skilled management team directing our day-to-day wins, and a Board with a stellar track record, we’re ready to take on the world’s diseases, ailments and adversity.

The Backbone of our Innovation

The Dova Board brings impressive experience to the table, bright minds from across the spectrum of relevant disciplines helping to illuminate the path forward for our pharmaceutical solutions.

Steven M. Goldman

Joined Dova Board: May 2017

Mr. Goldman is a Partner of Kramer Levin Naftalis & Frankel LLP, specializing in mergers and acquisitions, financings, joint ventures, private placements, leveraged buyouts and general corporate counseling. He has represented numerous banks in connection with financing of acquisitions and recapitalizations, and insurance brokerages in connection with regulatory enforcement issues and in purchase and sale transactions. From 2006 to 2009, before joining Kramer Levin, Mr. Goldman was the State of New Jersey’s Department of Banking and Insurance Commissioner, appointed by Governor Jon S. Corzine. He has held a number of other esteemed professional and civic roles, including serving on the Dean’s Board of Advisors for The George Washington University Law School. Mr. Goldman received his A.B. in Political Science from Boston University, his J.D. from the George Washington University and his L.L.M. in taxation from New York University.